Refine by MP, party, committee, province, or result type.

Results 16-23 of 23
Sorted by relevance | Sort by date: newest first / oldest first

International Trade committee  Thank you. Actually you mentioned the situation between the United States and the United Kingdom. In my example, I was using the United Kingdom as a very strong and positive model. It goes beyond just the data protection that's afforded in the European Union for inventing new

November 15th, 2011Committee meeting

David Skinner

International Trade committee  Thank you very much. Mr. Chairman and members of the committee, I'd like to start by thanking you for inviting Consumer Health Products Canada to provide our industry's perspective during the committee's review of a prospective comprehensive economic and trade agreement between

November 15th, 2011Committee meeting

David Skinner

Health committee  I can make a brief comment—and it goes back to a previous question as well—about what happens to products in international commerce and so on. The resources the government would have to have to pre-approve every single possible product that would ever come on the market before

June 2nd, 2009Committee meeting

David Skinner

Health committee  I don't think you even need to do that. I think the intention--and I believe it is possible within the “whereas” portions of the bill--is to make it clear for those who believe that natural health products, which make up 50% of our members' business, might be covered. The “wherea

June 2nd, 2009Committee meeting

David Skinner

Health committee  That's why in our testimony we're suggesting it's not inappropriate to release the information, especially about intellectual property, as that confers certain property rights to the owner of the property. You should at least be able to tell them that you're releasing the informa

June 2nd, 2009Committee meeting

David Skinner

Health committee  And the resources.

June 2nd, 2009Committee meeting

David Skinner

Health committee  Yes, we did. We made two proposals, one with respect to schedule 1 of Bill C-6. Rather than attempting to list all individual substances that may be found in the Food and Drugs Act, recognizing that from time to time new categories pop up and you'd be going back numerous times to

June 2nd, 2009Committee meeting

David Skinner

Health committee  Thank you, Madam Chair and members of the committee, for allowing me the opportunity to speak on behalf of the consumer health products industry on Bill C-6. My name is David Skinner, and I'm president of Consumer Health Products Canada, formerly known as NDMAC. Consumer Health

June 2nd, 2009Committee meeting

David Skinner